Abeona Therapeutics Earnings Estimate
| ABEO Stock | USD 5.12 0.08 1.54% |
Abeona Therapeutics Revenue Breakdown by Earning Segment
By analyzing Abeona Therapeutics' earnings estimates, investors can diagnose different trends across Abeona Therapeutics' analyst sentiment over time as well as compare current estimates against different timeframes. As of the 28th of February 2026, Gross Profit Margin is likely to grow to 0.51, though Gross Profit is likely to grow to (2.5 M). Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abeona Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
Abeona Therapeutics Earnings Estimation Breakdown
The calculation of Abeona Therapeutics' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Abeona Therapeutics is estimated to be -0.1033 with the future projection ranging from a low of -0.15 to a high of -0.05. Please be aware that this consensus of annual earnings estimates for Abeona Therapeutics is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.15 Lowest | Expected EPS | -0.05 Highest |
Abeona Therapeutics Earnings Projection Consensus
Suppose the current estimates of Abeona Therapeutics' value are higher than the current market price of the Abeona Therapeutics stock. In this case, investors may conclude that Abeona Therapeutics is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Abeona Therapeutics' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 6 | 48.49% | 0.0 | -0.1033 | 1.21 |
Abeona Therapeutics Earnings per Share Projection vs Actual
Actual Earning per Share of Abeona Therapeutics refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Abeona Therapeutics predict the company's earnings will be in the future. The higher the earnings per share of Abeona Therapeutics, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Abeona Therapeutics Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Abeona Therapeutics, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Abeona Therapeutics should always be considered in relation to other companies to make a more educated investment decision.Abeona Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Abeona Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
2025-11-12 | 2025-09-30 | -0.27 | -0.1 | 0.17 | 62 | ||
2025-08-14 | 2025-06-30 | -0.38 | 1.71 | 2.09 | 550 | ||
2025-05-13 | 2025-03-31 | -0.354 | -0.24 | 0.114 | 32 | ||
2025-03-17 | 2024-12-31 | -0.3433 | -0.3159 | 0.0274 | 7 | ||
2024-11-11 | 2024-09-30 | -0.4 | -0.3143 | 0.0857 | 21 | ||
2024-08-12 | 2024-06-30 | -0.36 | 0.19 | 0.55 | 152 | ||
2024-05-15 | 2024-03-31 | -0.51 | -1.16 | -0.65 | 127 | ||
2024-03-18 | 2023-12-31 | -0.47 | -0.77 | -0.3 | 63 | ||
2023-11-13 | 2023-09-30 | -0.53 | -0.48 | 0.05 | 9 | ||
2023-08-08 | 2023-06-30 | -0.68 | -0.92 | -0.24 | 35 | ||
2023-04-14 | 2023-03-31 | -0.58 | -0.54 | 0.04 | 6 | ||
2023-03-29 | 2022-12-31 | -0.75 | 1.53 | 2.28 | 304 | ||
2022-11-14 | 2022-09-30 | -1.75 | -1.48 | 0.27 | 15 | ||
2022-08-11 | 2022-06-30 | -1.87 | -2.08 | -0.21 | 11 | ||
2022-05-13 | 2022-03-31 | -2.37 | -3.5 | -1.13 | 47 | ||
2022-03-31 | 2021-12-31 | -3.67 | -3.5 | 0.17 | 4 | ||
2021-11-15 | 2021-09-30 | -4.06 | -4.0 | 0.06 | 1 | ||
2021-07-28 | 2021-06-30 | -4.12 | -4.0 | 0.12 | 2 | ||
2021-05-17 | 2021-03-31 | -4.67 | -4.25 | 0.42 | 8 | ||
2021-03-24 | 2020-12-31 | -2.5 | -4.25 | -1.75 | 70 | ||
2020-11-09 | 2020-09-30 | -3.58 | -2.0 | 1.58 | 44 | ||
2020-08-10 | 2020-06-30 | -4.25 | -3.5 | 0.75 | 17 | ||
2020-05-06 | 2020-03-31 | -6.11 | -4.0 | 2.11 | 34 | ||
2020-03-16 | 2019-12-31 | -7.75 | -7.5 | 0.25 | 3 | ||
2019-11-12 | 2019-09-30 | -10.89 | -8.75 | 2.14 | 19 | ||
2019-08-09 | 2019-06-30 | -8.74 | -12.25 | -3.51 | 40 | ||
2019-05-10 | 2019-03-31 | -7.96 | -9.75 | -1.79 | 22 | ||
2019-03-18 | 2018-12-31 | -9.95 | -10.5 | -0.55 | 5 | ||
2018-11-09 | 2018-09-30 | -6.39 | -8.5 | -2.11 | 33 | ||
2018-08-09 | 2018-06-30 | -4.75 | -6.25 | -1.5 | 31 | ||
2018-05-10 | 2018-03-31 | -4.67 | -4.5 | 0.17 | 3 | ||
2018-03-16 | 2017-12-31 | -3.49 | -4.75 | -1.26 | 36 | ||
2017-11-14 | 2017-09-30 | -4.63 | -3.25 | 1.38 | 29 | ||
2017-08-14 | 2017-06-30 | -3.65 | -5.25 | -1.6 | 43 | ||
2017-05-15 | 2017-03-31 | -3.75 | -3.25 | 0.5 | 13 | ||
2017-03-30 | 2016-12-31 | -3.4 | -4.75 | -1.35 | 39 | ||
2016-11-10 | 2016-09-30 | -4.65 | -2.0 | 2.65 | 56 | ||
2016-08-15 | 2016-06-30 | -4.06 | -5.0 | -0.94 | 23 | ||
2016-05-16 | 2016-03-31 | -3.25 | -4.25 | -1.0 | 30 | ||
2016-03-08 | 2015-12-31 | -3.06 | -1.75 | 1.31 | 42 | ||
2015-11-17 | 2015-09-30 | -2.75 | -4.75 | -2.0 | 72 | ||
2015-08-14 | 2015-06-30 | -2.33 | -4.0 | -1.67 | 71 | ||
2012-05-15 | 2012-03-31 | 87.5 | -62.5 | -150.0 | 171 | ||
2012-03-23 | 2011-12-31 | -37.5 | -150.0 | -112.5 | 300 | ||
2011-05-16 | 2011-03-31 | -187.5 | -175.0 | 12.5 | 6 | ||
2011-03-31 | 2010-12-31 | -250 | -250.0 | 0.0 | 0 | ||
2010-11-12 | 2010-09-30 | -137.5 | -225.0 | -87.5 | 63 | ||
2010-08-16 | 2010-06-30 | -137.5 | -87.5 | 50.0 | 36 | ||
2010-03-22 | 2009-12-31 | -250 | -975.0 | -725.0 | 290 | ||
2009-11-16 | 2009-09-30 | -287.5 | -462.5 | -175.0 | 60 | ||
2009-03-31 | 2008-12-31 | -712.5 | -387.5 | 325.0 | 45 | ||
2008-08-14 | 2008-06-30 | -550 | -612.5 | -62.5 | 11 | ||
2002-08-15 | 2002-06-30 | -937.5 | -1125.0 | -187.5 | 20 | ||
2002-03-28 | 2001-12-31 | -875 | -750.0 | 125.0 | 14 |
About Abeona Therapeutics Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Abeona Therapeutics earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Abeona Therapeutics estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Abeona Therapeutics fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -731.9 M | -695.3 M | |
| Retained Earnings Total Equity | -513.6 M | -488 M | |
| Earnings Yield | (0.32) | (0.34) | |
| Price Earnings Ratio | (4.13) | (3.92) | |
| Price Earnings To Growth Ratio | 0.09 | 0.11 |
Pair Trading with Abeona Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abeona Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abeona Therapeutics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Abeona Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abeona Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abeona Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abeona Therapeutics to buy it.
The correlation of Abeona Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abeona Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abeona Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abeona Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abeona Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Will Biotechnology sector continue expanding? Could Abeona diversify its offerings? Factors like these will boost the valuation of Abeona Therapeutics. If investors know Abeona will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Abeona Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 1.21 | Revenue Per Share | Quarterly Revenue Growth (1.00) | Return On Assets | Return On Equity |
Investors evaluate Abeona Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Abeona Therapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Abeona Therapeutics' market price to deviate significantly from intrinsic value.
Understanding that Abeona Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Abeona Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Abeona Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.